NCT03986502View on ClinicalTrials.gov

Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnosed Gastric or Gastroesophageal Junction Adenocarcinoma

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2022

Conditions

Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma

Interventions

OTHER

Media Intervention

Watch web-based financial literacy video

OTHER

Informational Intervention

Receive information on financial counseling and medical cost assistance

OTHER

Best Practice

Utilize usual clinic procedures and clinic or community-based financial resources

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Quality-of-Life Assessment

Ancillary studies

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors

collaborator

Eli Lilly and Company

INDUSTRY

lead

Fred Hutchinson Cancer Center

OTHER

NCT03986502 - Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnosed Gastric or Gastroesophageal Junction Adenocarcinoma | Biotech Hunter | Biotech Hunter